Navigation Links
89 North Wins Prestigious International Award
Date:2/6/2012

BURLINGTON, Vt., Feb. 6, 2012 /PRNewswire/ -- After only three years in business, 89 North won the prestigious 2011 Prism Award from the International Society for Optics and Photonics (SPIE) on Jan. 25. The award was for new products in the category of  "Life Sciences and Biophotonics."

The new product is 89 North's Heliophor, a patent-pending, innovative, high-intensity and exceptionally stable new light source used for quantitative fluorescence imaging in a wide variety of applications, including cancer research. A pumped-phosphor light engine, the Heliophor's stability and straightforward calibration system ensure that output intensity is consistent across measurements, allowing repeatable, truly quantitative fluorescent analysis.

The Prism Award was presented to 89 North at a gala banquet in San Francisco at SPIE's Photonics West Conference. SPIE gives the award "to products that challenge conventional ideas, solve problems, and improve life through the generation and harnessing of light."

SPIE was founded in 1955 to advance light-based technologies. Serving more than 180,000 constituents from 168 countries, the Society advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth.

"The Heliophor provides a new alternative to arc lamps, metal halides, and LED light sources," SPIE said.

"The quality and competition among this year's entries was even keener than in past years," said SPIE CEO Eugene Arthurs. "More companies submitted applications than ever before. The strength of applications from core companies in our industry along with the impressive innovations bubbling up from smaller companies really demonstrates the vitality of the photonics industry."

89 North (www.89north.com), located in Burlington, Vermont, is a subsidiary of Bellow Falls' award-winning Chroma Technology Corp. (www.chroma.com). Chroma is a global employee-owned company manufacturing precision optical filters and coatings for biomedical instruments such as flow cytometers, plate readers and fluorescence microscopes.

"We created 89 North to encourage the kind of innovations that emerge when smart and creative people interact," said Chroma President Paul Millman. "The Prism award certifies the success of that interaction."

 

 


'/>"/>
SOURCE Chroma Technology Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
3. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
5. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
6. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
7. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
8. Northwestern Memorial Transplant Program Initiates New Study
9. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
10. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
11. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... YORK , January 24, 2017 ... Ltd (NASDAQ: GENE ), Alder Biopharmaceuticals Inc. (NASDAQ: ... BDSI ), and Egalet Corp. (NASDAQ: EGLT ... was moderately lower on Monday, January 23 rd , 2017, ... shares of health care companies in the S&P 500 also ...
(Date:1/24/2017)... 2017 INTRODUCTION Injectable drug delivery systems ... with vials to prefilled syringes, auto-injectors, pen injectors ... become preferred devices for parenteral administration of drugs. ... rising strongly over the past several years. A ... this format for delivering drugs. The popularity of ...
(Date:1/24/2017)... LONDON , Jan. 23, 2017 The ... revenue in 2015, and it is expected to grow ... peripheral I.V. catheter segment accounted for larger share in ... whereas, among the various end users, the hospital segment ... during the same year. The global peripheral I.V. catheter ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... “Spiritual Vitamins: A ... connection with God. “Spiritual Vitamins: A Spiritual Energy Booster” is the creation of ... Publishing, Mathai Yohannan’s new book engages the mind and spirit in a quest ...
(Date:1/24/2017)... ... 2017 , ... Attention women who want bigger breasts but ... fat grafting—taking one’s own fat and putting it in other body part—is a ... Surgeon and Medical Director of MilfordMD Cosmetic Dermatology Surgery & Laser Center, in ...
(Date:1/24/2017)... ... January 23, 2017 , ... United ... the imposition of the Mexico City Policy, also known as the Global Gag ... through Executive action, prohibits foreign non-governmental organizations from receiving any U.S. foreign assistance ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... support them, Dr. Carol Francis, Psychologist in the South Bay area , ... respectful governing for all people and by all people shines as a bright ...
(Date:1/23/2017)... ... , ... PKF O’Connor Davies , LLP, the nation’s 26th largest accounting ... Firm, will participate in the 40th Annual "Empire State Building Run Up" on Feb. ... steps, a vertical distance equal to about a fifth of a mile, to reach ...
Breaking Medicine News(10 mins):